1. LncRNA SOX2OT promotes temozolomide resistance by elevating SOX2 expression via ALKBH5-mediated epigenetic regulation in glioblastoma
    Boyang Liu et al, 2020, Cell Death & Disease CrossRef
  2. Identification of a multidimensional transcriptome signature for survival prediction of postoperative glioblastoma multiforme patients
    Wei-Zhen Gao et al, 2018, Journal of Translational Medicine CrossRef
  3. IRP1 mediated ferroptosis reverses temozolomide resistance in glioblastoma via affecting LCN2/FPN1 signaling axis depended on NFKB2
    Yufei Lan et al, 2023, iScience CrossRef
  4. Identification of Prognostic Biomarkers for Glioblastoma Based on Transcriptome and Proteome Association Analysis
    Jiabin Wang et al, 2022, Technology in Cancer Research & Treatment CrossRef
  5. PSMG3‐AS1 enhances glioma resistance to temozolomide via stabilizing c‐Myc in the nucleus
    Li Zhou et al, 2022, Brain and Behavior CrossRef
  6. Potential Use of Long Noncoding RNAs as Biomarkers for Astrocytoma
    Ruth Ruiz Esparza-Garrido et al, 2019, Primary Intracranial Tumors CrossRef
  7. Molecular mechanisms in temozolomide-resistant glioblastoma
    Sang Y. Lee et al, 2021, Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies CrossRef
  8. Role of Long Non-Coding RNAs in Conferring Resistance in Tumors of the Nervous System
    Soudeh Ghafouri-Fard et al, 2021, Frontiers in Oncology CrossRef
  9. Comprehensive analysis of differentially expressed profiles of long non-coding RNAs and messenger RNAs in kaolin-induced hydrocephalus
    Yan-Hui Shi et al, 2019, Gene CrossRef
  10. Regulation of temozolomide resistance via lncRNAs: Clinical and biological properties of lncRNAs in gliomas (Review)
    Sui Li et al, 2022, International Journal of Oncology CrossRef
  11. Fibronectin Promotes the Malignancy of Glioma Stem-Like Cells Via Modulation of Cell Adhesion, Differentiation, Proliferation and Chemoresistance
    Qi Yu et al, 2018, Frontiers in Molecular Neuroscience CrossRef
  12. Bivalent activity of super-enhancer RNA LINC02454 controls 3D chromatin structure and regulates glioma sensitivity to temozolomide
    Tengfei Shi et al, 2024, Cell Death & Disease CrossRef
  13. miR-1268a regulates ABCC1 expression to mediate temozolomide resistance in glioblastoma
    Yaomin Li et al, 2018, Journal of Neuro-Oncology CrossRef
  14. miR-126-3p sensitizes glioblastoma cells to temozolomide by inactivating Wnt/β-catenin signaling via targeting SOX2
    Wenzheng Luo et al, 2019, Life Sciences CrossRef
  15. Exosome-mediated transfer of MIF confers temozolomide resistance by regulating TIMP3/PI3K/AKT axis in gliomas
    Q.T. Wei et al, 2021, Molecular Therapy - Oncolytics CrossRef
  16. Long Non-Coding RNAs in Multidrug Resistance of Glioblastoma
    Parvaneh Mahinfar et al, 2021, Genes CrossRef
  17. Mechanisms of Long Non-Coding RNAs in Biological Characteristics and Aerobic Glycolysis of Glioma
    Ningning Zhao et al, 2021, International Journal of Molecular Sciences CrossRef
  18. Identifying Predictive Gene Expression and Signature Related to Temozolomide Sensitivity of Glioblastomas
    Hong-Qing Cai et al, 2020, Frontiers in Oncology CrossRef
  19. PathCNN: interpretable convolutional neural networks for survival prediction and pathway analysis applied to glioblastoma
    Jung Hun Oh et al, 2021, Bioinformatics CrossRef
  20. Scrutinizing the landscape of DNA methylation epigenetic face(s) in glioblastomas
    Nadia M. Hamdy et al, 2024, Nutraceutical Fruits and Foods for Neurodegenerative Disorders CrossRef
  21. Long Noncoding RNA WEE2-AS1 Plays an Oncogenic Role in Glioblastoma by Functioning as a Molecular Sponge for MicroRNA-520f-3p
    Hengzhou Lin et al, 2020, Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics CrossRef
  22. Crosstalk between SOX Genes and Long Non-Coding RNAs in Glioblastoma
    Milena Stevanovic et al, 2023, International Journal of Molecular Sciences CrossRef
  23. lncRNA XLOC013218 promotes cell proliferation and TMZ resistance by targeting the PIK3R2‐mediated PI3K/AKT pathway in glioma
    Jian Zhou et al, 2022, Cancer Science CrossRef
  24. IL-18, a therapeutic target for immunotherapy boosting, promotes temozolomide chemoresistance via the PI3K/AKT pathway in glioma
    Huangyi Ji et al, 2024, Journal of Translational Medicine CrossRef
  25. Long noncoding RNA AC003092.1 promotes temozolomide chemosensitivity through miR-195/TFPI-2 signaling modulation in glioblastoma
    Ningbo Xu et al, 2018, Cell Death & Disease CrossRef
  26. Identification of a universal 6‐lncRNA prognostic signature for three pathologic subtypes of renal cell carcinoma
    Shuguang Zuo et al, 2019, Journal of Cellular Biochemistry CrossRef
  27. Detailed Molecular Mechanism and Potential Drugs for COL1A1 in Carboplatin-Resistant Ovarian Cancer
    Feng Yang et al, 2021, Frontiers in Oncology CrossRef
  28. Hippo Pathway in Regulating Drug Resistance of Glioblastoma
    Giacomo Casati et al, 2021, International Journal of Molecular Sciences CrossRef
  29. Long non-coding RNA ENST01108 promotes carcinogenesis of glioma by acting as a molecular sponge to modulate miR-489
    Dawei Xu et al, 2018, Biomedicine & Pharmacotherapy CrossRef